Ohio State Navbar

Directory

Brad H. Rovin, MD - Director


Staff photo

395 W 12th Ave
Columbus, OH 43210

Phone: (614) 293-4997

Email: rovin.1@osu.edu

 

Current OSU Appointments

Professor, Nephrology

Professor, Pathology

Physician, FGP-Nephrology

 

Advising Narrative

Rovin, B.H., J. Dickerson, L. Tan, and C. Hebert: Activation of nuclear factor-kappaB correlates with MCP-1 expression by human mesangial cells, Kidney Int., 48:1263-1271, 1995. Rovin, B.H., L. Lu, and A.M. Cosio: Cyclopentenone prostaglandins inhibit cytokine-induced NF-B activation and chemokine production by human mesangial cells. J. Am. Soc. Nephrol., 12:1659-1667, 2001.

Certifications

1986 - present Board Certification (Diplomate): American Board of Internal Medicine
1988 - present Board Certification (Diplomate): American Board of Internal Medicine
1990 - present Medical Licensure: State Medical Board of Ohio
 

Chapters in Books

Rovin BH. "Renal Diseases." In Manual of Medical Therapeutics. Edited by W. Dunagan and M. Ridner. 221-. Boston, MA: Little Brown, January 1989.

Lefkowith JB, Rovin BH, and Schreiner GF. "Depletion of Resident Glomerular Macrophages by Essential Fatty Acid Deficiency Protects against Glomerulonephritis." In Adv. Prostaglandi, Thromboxane and Leukotriene Res. Edited by 560. Samuelsson B, Sun F, Wang P-. New York: Raven Press Ltd, January 1989.

Schreiner GF and Rovin BH. "The role of dietary fatty acides in progressive renal disease." In Continuing Issues in Nephrology. Edited by Keane WF. 149-. New York: Churchill Livingstone, January 1991.

Rovin BH. "An Outpatient Approach to Proteinuria." In Nephrology in Primary Care. Edited by A. Mandal and N.S. Nahman, Jr.. -. Baltimore: William and Wilkins, January 1998.

Rovin, B.H. "Primary Glomerular Diseases." In Conn’s Current Therapy. Edited by R.E. Rakel. 675-. Philadelphia: W.B Saunders, January 2000.

Rovin BH. "Primary Glomerular Diseases." In Conn's Current Therapy. Edited by R. E. Rakel. 726-. Philadelphia: W. B. Saunders, January 2004.

Saxena R and Rovin BH. "Glomerular Diseases." In Nephrology for the Asian-Pacific Physician. Edited by A. Mandal and A. Agarwal. -. New Delhi, India: J.P. Brothers, January 2004.

Yang Y, Chung E, Zhou B, Lhotta K, Hebert LA, Birmingham DJ, Rovin BH and Yu, Y. "The intricate role of complement component C4 in human SLE." In Complement in Autoimmunity. Edited by GC Tsokos. 98-132. Karger, January 2004.

Yang Y, Chunh EK, Lhota K, Wu YL, Higgins GC, Rennebohm RM, Hebert LA, Birmingham DJ, Rovin BH and Yu CY. "Complement components C4A and C4B in human lupus." In Molecular Autoimmunity. Edited by Moncek Zouali. -. Kluwer Academic Publishers, January 2005.

Yu, C.Y., G. Hauptmann, Y. Yang, Y.L. Wu, D.J. Birmingham, B.H. Rovin, and L.A. Hebert. "Complement deficiencies in human systemic lupus erythematosus (SLE) and SLE nephritis: epidemiology and pathogenesis." In Systemic Lupus Erythematosus: A Companion to Rheumatology. Edited by Tsokos, G.C., Gordon, C., and Smolen, J.S.. 183-193. Philadelphia: Elsevier, January 2007.

Rovin BH, Stillman IE. "The Kidney in System Lupus Erythematosus." In Systemic Lupus Erythematosus, Fifth Edition. Edited by : Lahita RG, Koike T, Buyon J, Tsokos G. -. Unk: Elsevier, January 2010.

 

Degrees

1978 B.S., Northwestern University

 

Editorial Activities

present The Open Urology and Nephrology Journal
present The Open Urology and Nephrology Journal
present New England Journal of Medicine
present Journal of Nephrology
present Immunology Today
present Clinical Journal of the American Society of Nephrology
present Clinical Immunology and Immunopathology
present American Journal of Kidney Disease
present American Heart Journal
present Kidney International
present Journal of Laboratory and Clinical Medicine
present Journal of Clinical Investigation
present ISRN Rheumatology
present Frontiers in Bioscience
present Arthritis and Rheumatism
present American Journal of Physiology
present American Journal of Pathology
present Urology
present Journal of Immunology
present Nephron
present Journal of the American Society of Nephrology
1996 - 2001 American Journal of Kidney Disease
1998 - present Kidney International
1998 - 2004 Journal of the American Society of Nephrology
2009 - present NIDDK Study Section: Challenge Grant Content Review
2009 - present State of Pennsylvania: Medical Research Grants
2010 - present Clinical Nephrology
 

Honors

0 Alpha Omega Alpha. Medical Honor Society.
0 William J Grove Award, Outstanding Medical Graduate.
0 Omega chi Epsilon. Institute of Chemists Award.
0 American Insitute of Chemists Award.
0 American College of Physicians.
0 James Scholar. College of Medicine.
0 American Society of Nephrology.
0 Medical Student Research Forum, First Place.
0 Alpha Omega Alpha Medical Honor Society.
1989 - 1990 Young Investigator Award.
1994 - 1995 Clinical Scientist Award.
2004 Ranked in US News and World Report.
2005 - 2007 America's Best Doctors. U.S. News & World Report.
2007 - 2009 America's Best Doctors.
2008 America's Best Doctor's List.
 

Journal Articles

Tesler A and Rovin BH. "A specific stain for sulfhydryl groups in proteins after separation by polyacrylamide gel eletrophoresis." Biochimica et Biophysica Acta. Vol. 624, (January 1980.): 363-371.

Telser, A; Rovin, B. "A specific stain for sulfhydryl groups in proteins after separation by polyacrylamide gel electrophoresis.." Biochimica et biophysica acta. Vol. 624, no. 2. (January 1980.): 363-71.

Rovin, B., J. Molnar, D. Chevalier, P. Ng. "Interaction of Plasma Fibronectin with Membranous Constituents of Peritoneal Exudate Cells and Pulmonary Macrophages." J. Leukocyte Biology. Vol. 36, (January 1984.): 601-620.

Lefkowith, J, B; Rovin, B; Schreiner, G F. "Depletion of resident glomerular macrophages by essential fatty acid deficiency protects against glomerulonephritis.." Advances in prostaglandin, thromboxane, and leukotriene research. Vol. 19, (January 1989.): 560-3.

Schreiner, G, F; Rovin, B; Lefkowith, J B. "The antiinflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis. The modulation of macrophage migration and eicosanoid metabolism.." Journal of immunology (Baltimore, Md. : 1950). Vol. 143, no. 10. (January 1989.): 3192-9.

Rovin, B, H; Wurst, E; Kohan, D E. "Production of reactive oxygen species by tubular epithelial cells in culture.." Kidney international. Vol. 37, no. 6. (January 1990.): 1509-14.

Rovin, B, H; Lefkowith, J, B; Schreiner, G F. "Mechanisms underlying the anti-inflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis. Inhibited release of a monocyte chemoattractant by glomeruli.." Journal of immunology (Baltimore, Md. : 1950). Vol. 145, no. 4. (January 1990.): 1238-45.

Rovin, B, H; Harris, K, P; Morrison, A; Klahr, S; Schreiner, G F. "Renal cortical release of a specific macrophage chemoattractant in response to ureteral obstruction.." Laboratory investigation; a journal of technical methods and pathology. Vol. 63, no. 2. (January 1990.): 213-20.

Muir, A; Rovin, B, H; Lacy, P, E; Schreiner, G F. "Macrophage-specific chemotactic lipid release by in vivo streptozocin-administered mouse islets.." Diabetes. Vol. 40, no. 11. (January 1991.): 1459-66.

Muir A, Rovin BH, Lacy PE, Schreiner GF. "Murine islets treated with in vivo streptozotocin release a macrophage specific chemotactic lipid." Diabetes. Vol. 40, (January 1991.): 1459-1466.

Rovin, B.H., and G.F. Schreiner. "The role of lipids in renal macrophage accumulation." OSU Res. Forum. Vol. 5, (January 1991.): 7-10.

Rovin, B.H., and G.F. Schreiner. "Cell-Mediated Immunity in Glomerular Disease." Ann. Rev. Med. Vol. 42, (January 1991.): 25-33.

Rovin, B.H., T. Yoshimura, and L. Tan. "Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells." J. Immunol. Vol. 148, (January 1992.): 2148-2153.

Rovin, B, H; Tan, L C. "LDL stimulates mesangial fibronectin production and chemoattractant expression.." Kidney international. Vol. 43, no. 1. (January 1993.): 218-25.

Rovin, B, H; Bou-Khalil, P; Sedmak, D. "Pulmonary-renal syndrome in a patient with fibrillary glomerulonephritis.." American journal of kidney diseases : the official journal of the National Kidney Foundation. Vol. 22, no. 5. (January 1993.): 713-6.

Cosio, F, G; Shibata, T; Rovin, B, H; Birmingham, D J. "Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells.." Kidney international. Vol. 46, no. 4. (January 1994.): 986-92.

Rovin, B, H; Tan, L C. "Role of protein kinase pathways in IL-1-induced chemoattractant expression by human mesangial cells.." Kidney international. Vol. 46, no. 4. (January 1994.): 1059-68.

Rovin, B, H; Rumancik, M; Tan, L; Dickerson, J. "Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis.." Laboratory investigation; a journal of technical methods and pathology. Vol. 71, no. 4. (January 1994.): 536-42.

Rovin, B, H; Tan, L, C; Leonhart, K, L; Nahman, N S Jr. "Cyclic adenosine monophosphate and protein kinase C modulate fibronectin production in cultured human mesangial cells.." The Journal of laboratory and clinical medicine. Vol. 126, no. 2. (January 1995.): 216-23.

Rovin, B, H; Dickerson, J, A; Tan, L, C; Hebert, C A. "Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells.." Kidney international. Vol. 48, no. 4. (January 1995.): 1263-71.

Rovin, B, H; Doe, N; Tan, L C. "Monocyte chemoattractant protein-1 levels in patients with glomerular disease.." American journal of kidney diseases : the official journal of the National Kidney Foundation. Vol. 27, no. 5. (January 1996.): 640-6.

Wilmer, W, A; Tan, L, C; Dickerson, J, A; Danne, M; Rovin, B H. "Interleukin-1beta induction of mitogen-activated protein kinases in human mesangial cells. Role of oxidation.." The Journal of biological chemistry. Vol. 272, no. 16. (January 1997.): 10877-81.

Rovin, B, H; Dickerson, J, A; Tan, L, C; Fassler, J. "Modulation of IL-1-induced chemokine expression in human mesangial cells through alterations in redox status.." Cytokine. Vol. 9, no. 3. (January 1997.): 178-86.

Marsh, C, B; Wewers, M, D; Tan, L, C; Rovin, B H. "Fc(gamma) receptor cross-linking induces peripheral blood mononuclear cell monocyte chemoattractant protein-1 expression: role of lymphocyte Fc(gamma)RIII.." Journal of immunology (Baltimore, Md. : 1950). Vol. 158, no. 3. (January 1997.): 1078-84.

Marsh, C, B; Lowe, M, P; Rovin, B, H; Parker, J, M; Liao, Z; Knoell, D, L; Wewers, M D. "Lymphocytes produce IL-1beta in response to Fcgamma receptor cross-linking: effects on parenchymal cell IL-8 release.." Journal of immunology (Baltimore, Md. : 1950). Vol. 160, no. 8. (January 1998.): 3942-8.

BH Rovin and LT Phan. "Chemotactic Facotrs and Renal Inflammation." American Journal of Kidney Disease. Vol. 31, (January 1998.): 1065-1084.

Rovin, B.H. and L.T. Phan. "Chemotactic Factors and Renal Inflammation." Am. J. Kidney Dis. Vol. 31, (January 1998.): 1065-1084.

Rovin, B, H; Wilmer, W, A; Danne, M; Dickerson, J, A; Dixon, C, L; Lu, L. "The mitogen-activated protein kinase p38 is necesssary for interleukin 1beta-induced monocyte chemoattractant protein 1 expression by human mesangial cells.." Cytokine. Vol. 11, no. 2. (January 1999.): 118-26.

Rovin, B, H; Lu, L; Saxena, R. "A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression.." Biochemical and biophysical research communications. Vol. 259, no. 2. (January 1999.): 344-8.

Rovin, B H. "Chemokines as therapeutic targets in renal inflammation.." American journal of kidney diseases : the official journal of the National Kidney Foundation. Vol. 34, no. 4. (January 1999.): 761-4; discussion 765.

Rovin, B.H. "Chemokines as Therapeutic Targets in Renal Inflammation." Am. J. Kidney Dis. no. 34. (January 1999.): 761-766.

Rovin, B.H. "Chemokine Blockade as a Therapy for Renal Diseas." Current Opinion in Nephrology and Hypertension 9/3. Vol. 9, (January 2000.): 225-232.

Kniss, D, A; Rovin, B; Fertel, R, H; Zimmerman, P D. "Blockade NF-kappaB activation prohibits TNF-alpha-induced cyclooxygenase-2 gene expression in ED27 trophoblast-like cells.." Placenta. Vol. 22, no. 1. (January 2001.): 80-9.

Birmingham, D.J., B.H. Rovin, C.Y. Yu, and L.A. Hebert. "Of mice and men: The relevance of the mouse to the study of human SLE." Immunologic Res. Vol. 24, (January 2001.): 211-224.

Rovin, B, H; Lu, L; Marsh, C B. "Lymphocytes induce monocyte chemoattractant protein-1 production by renal cells after Fc gamma receptor cross-linking: role of IL-1beta.." Journal of leukocyte biology. Vol. 69, no. 3. (January 2001.): 435-9.

Hebert, L, A; Wilmer, W, A; Falkenhain, M, E; Ladson-Wofford, S, E; Nahman, N S Jr; Rovin, B H. "Renoprotection: one or many therapies?." Kidney international. Vol. 59, no. 4. (January 2001.): 1211-26.

Wilmer, W, A; Dixon, C; Lu, L; Hilbelink, T; Rovin, B H. "A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma.." Biochemical and biophysical research communications. Vol. 281, no. 1. (January 2001.): 57-62.

Rovin, B.H. "Beyond a glomerulocentric view of inflammation." Kidney Int. Vol. 60, (January 2001.): 797-798.

Rovin, B, H; Lu, L; Cosio, A. "Cyclopentenone prostaglandins inhibit cytokine-induced nf-kappab activation and chemokine production by human mesangial cells.." Journal of the American Society of Nephrology : JASN. Vol. 12, no. 8. (January 2001.): 1659-67.

Rovin, B H. "Beyond a glomerulocentric view of inflammation.." Kidney international. Vol. 60, no. 2. (January 2001.): 797-8.

Wilmer, W.A., C.L. Dixon, C. Hebert, L. Lu, and B.H. Rovin. "PPAR� ligands inhibit H2O2-mediated activation of TGF-�1 in human mesangial cells." Antioxidant. Redox Signal. Vol. 4, (January 2002.): 877-884.

Rovin, B.H., W.A. Wilmer, L. Lu, A.I. Doseff, C. Dixon, M. Kotur, and T. Hilbelink. "15-deoxy-�12,14-prostaglandin J2 regulates mesangial cell proliferation and death." Kidney International. Vol. 61, (January 2002.): 1293-1302.

Rovin BH, Lu L, Zhang X. "A novel interleukin-8 polymorphism is associated with severe SLE nephritis." Kidney International. Vol. 62, (January 2002.): 261-265.

Randolph-Habecker JB, Rahill B, Torok-Storb B, Vieira J, Kolattukudy P, Rovin B and Sedmak D. "The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 production.." Cytokine. Vol. 19, (January 2002.): 37-43.

Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mummidi S, Kulkarni H, Bamshad MJ, Telles V, Anderson SA, Walter EA, Stephan KT, Deucher M, Mangano A, Bologna R, Shuja SS, Dolan MJ, Ahuja SK. "HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels,." Proceedings of the National Academy of Science USA. (January 2002.): -.

Atalay, Mustafa; Gordillo, Gayle; Roy, Sashwati; Rovin, Brad; Bagchi, Debasis; Bagchi, Manashi; Sen, Chandan K. "Anti-angiogenic property of edible berry in a model of hemangioma.." FEBS letters. Vol. 544, no. 1-3. (January 2003.): 252-7.

Wilmer, W.A., B.H. Rovin, C.J. Hebert, S.V. Rao, K. Kumor, and L.A. Hebert. "Management of glomerular proteinuria: A commentary." J. Am. Soc. Nephrol. Vol. 14, (January 2003.): 3217-3232.

Kelley, V.R. and B.H. Rovin. "Chemokines: Therapeutic targets for autoimmune and inflammatory renal disease." Springer Semin. Immunopathol. Vol. 24, (January 2003.): 411-421.

Zhang X, Chen HZ, Rovin BH. "Unexpected sensitivity of synthetic Renilla luciferase control vectors to treatment with a cyclopentenone prostaglandin." Bio Techniques. Vol. 35, (January 2003.): 1144-1148.

Zhang, X., L. Lu, C. Dixon, W. Wilmer, H. Song, X. Chen, and B.H. Rovin. "Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-�12,14-prostaglanding J2 in human mesangial cells." Kidney International. Vol. 65, (January 2004.): 798-810.

Spetie DN, Tang Y, Rovin BH, Nadasdy T, Nadasdy G, Pesavento TE, and Hebert LA. "Mycophenolate therapy of SLE mambranous nephropathy." Kidney International. Vol. 66, (January 2004.): 2411-2415.

Thongboonkerd V, Barati M, McLeish KR, Benarafa C, Remold-O'Donnell E. Zheng S. Rovin BH, Pierce WM, Epsteri PN, Klein JB. "Alterations in the renal elastin-elastase system in type I diabetic nephropathy identified by proteomic analysis." Journal of the American Society of Nephrology. Vol. 15, (January 2004.): 650-663.

Ackerman WE, Rovin BH, Kniss DA. "Epidermal growth factor and interleukin-1 utilize divergent signaling pathways to synergistically upregular cyclooxygenase-2 gene expression in human amnion-derived WISH cells." Biology Reproduction. Vol. 71, (January 2004.): 2079-2086.

Rovin BH, Tang Y, Sun J, Nagaraja HN, Hackshaw KV, Gray L, Rice R, Birmingham DJ, Yu CY, Spetie DN, Aziz A, Hebert LA. "Clinical significant of fever in the SLE patient receiving steroid therapy." Kidney International. Vol. 68, (January 2005.): 747-759.

Rovin BH, Song H, Hebert LA, Nadasdy T, Nadasdy G, Birmingham DJ, Yu CY, and Nagaraja HN. "Plasma, urine and renal expression of adiponectin in human systemic lupus erythematosus." Kidney International. Vol. 68, (January 2005.): 1825-1833.

Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu C-Y, Nagaraja HN. "Urine chemokines as biomarkers of human SLE activity." Journal of the American Society of Nephrology. Vol. 16, (January 2005.): 467-473.

Wu H, Cantor RM, Graham DC, Lingren CM, Farwell L, DeJager PK, Bottini N, Grossman JM, Wallace DJ, Hahn BH, Julkunen H, Hebert LA, Rovin VH, Birmingham DJ, Rious CY, Yu J, Kere J, Vyse and Tsao, BP TJ. "Association analysis of the R620W polymorphism of protein tyrosine phosphastase PtPN22 in SLE families: Increased T allele frequency in those with authoimmune thyroid disease." Athritis & Rheumatism. Vol. 52, (January 2005.): 2396-2402.

Gonzalez, Kulkarni , Bolivar H, Mangano A, Sanche R, Catano G, Nibbs R, Freedman BI, Quiones MP, Murphy KK, Rovin BH, Bamshad MJ, Bradley W, Clark RA, Anderson SA, O'Connell RJ, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan NJ, Ahuja SK. "CCL3L1 gene-containing segmental duplications in HIV-1/AIDS susceptibility." Science. Vol. 307, (January 2005.): 1434-1440.

Rovin, B.H., H. Song, D.J. Birmingham, L.A. Hebert, C.-Y. Yu, and H.N. Nagaraja. "Urine chemokines as biomarkers of human SLE activity." J. Am. Soc. Nephrol. Vol. 16, (January 2005.): 467-473.

Zhang, X., X. Chen, H. Song, H.-Z. Chen, and B.H. Rovin. "Activation of the Nrf2/antioxidant response pathway increases IL-8 expression." Eur. J. Immunol. Vol. 35, (January 2005.): 3258-3267.

Zhang X, Chen X, Song H, Chen HZ and Rovin BH. "Activation of the Nrf2/antioxidant response pathway increases iL-8 expression." European Journal of Immunology. Vol. 35, (January 2005.): 3258-3267.

Hebert LA, Rovin BH, AGarwal AK, Spetie DN. "Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression." American Journal of Kidney Disease. Vol. 45, (January 2005.): 788-789.

Hebert L.A., Rovin, B.H., Agarwal, A.K., and Spetie, D.N. "Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression." Am. J. Kidney Dis. Vol. 45, (January 2005.): 788-789.

Ackerman WE, Zhang XL, Rovin BH, Kniss DA. "Modulation of cytokine-induced cyclooxygenase 2 expression by PPARy ligands through NF-kB signal disruption in human WISH and amnion cells." Biology Reproduction. Vol. 73, (January 2005.): 527-535.

Birmingham, D, J; Gavit, K, F; McCarty, S, M; Yu, C, Y; Rovin, B, H; Nagaraja, H, N; Hebert, L A. "Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare.." Clinical and experimental immunology. Vol. 143, no. 2. (January 2006.): 274-80.

Byrd JC, Lin TS, Dalton JT, Wu D, Phelps MA, Fisher B, Moran M, Blum KA, Rovin BH, Booker-McEldowney M, Broering S, Schaaf LJ, Johnson AJ, Lucas DM, Heerema NA, Lozanski G, Young DC, Suerez JR, Colevas AD, Grever MR. "Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytis leukemia." Blood. (January 2006.): -.

Rovin BH, Song H. "Chemokine induction by the adipocyte-derived cytokine adiponectin." Clinical Immunology. Vol. 120, (January 2006.): 99-105.

Xie, Y; Kang, ; XAckerman, W E 4th; Belury, M, A; Koster, C; Rovin, B, H; Landon, M, B; Kniss, D A. "Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins.." Diabetes, obesity & metabolism. Vol. 8, no. 1. (January 2006.): 83-93.

Birmingham DJ, Nagaraja HN, Rovin BH, Spetie L, Zhao Y, Hackshaw KV, Yu CY, Malarkey WB, and Hebert LA. "Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carryting the serotonin receptor 1A-1019 G allele." Arthritis & Rheumatism. Vol. 54, (January 2006.): 3291-3299.

Birmingham DJ, Gavit KF, McCarty SM, Tong J, Yu, CK, Rovin BH, Ngaraja HN and Hebert LA. "Consumption of erythrocyte complement receptor type one is associated with protection against SLE flare." Clinical Experience Immunology. Vol. 143, (January 2006.): 274-280.

Chen K, Dodd G, thomas S, Zhang X, Wasserman MA, Rovin, BH and Kusch C. "Activation of the Nrf2/antioxidant response element pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expresiion." American Hournal of Physiology. Vol. 290, (January 2006.): H1862-H1870.

Wu, Y.L., G.C. Higgins, R.M. Rennebohm, E.K. Chung, Y. Yang, B. Zhou, H.N. Nagaraja, D.J. Birmingham, B.H. Rovin, L.A. Hebert, and C.Y. Yu. "Three distinct profiles of serum complement component C4 proteins in pediatric systemic lupus erythematosus patients: tight associations of complement C4 and C3 protein levels in SLE but not in healthy subjects." Adv. Exp. Med. Biol. Vol. 586, (January 2006.): 227-247.

Wang, L., S. Lin, K.W. Rammohan, Z. Liu, J.-Q. Liu, R.-H. Liu, N. Guinther, J. Lima, Q. Zhou, T. Wang, Z. Zheng, D.J. Birmingham, B.H. Rovin, L.A. Hebert, Y. Wu, J. Lynn, G. Cooke, C.Y. Yu, P. Zheng, and Y. Liu. "A di-nucleotide deletion in CD24 confers protection against autoimmune diseases,." PLoS Genetics. Vol. 3e:49, (January 2007.): -.

Hebert, L.A., B.H. Rovin, and C.J. Hebert. "The design of the ALLHAT may have biased the study’s outcome in favor of the diuretic cohort." Nature Clinical Practice Nephrology. Vol. 3, (January 2007.): 60-61.

Yang, Y., E.K. Chung, Y.L. Wu, S. Savelli, H.N. Nagaraja, B. Zhou, M. Hebert, K. Jones, Y. Shu, K. Kitzmiller, C.A. Blanchong, N. Jacobsen-Longman, K. McBride, G.C. Higgens, R.M. Rennebohm, R.R. Rice, K.V. Hackshaw, R.A. Roubey, J.M. Grossman, B.P. Tsao,. "Gene copy number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus: Low copy number is a risk factor for, high copy number is a protective factor against, Caucasian SLE disease susceptibility." American Journal of Human Genetics. (January 2007.): 1037-1054.

Wu, Y.L., S.L. Savelli, Y. Yang, B. Zhou, B.H. Rovin, D.J. Birmingham, H.N. Nagaraja, L.A. Hebert, and C.Y. Yu. "Sensitive and specific real-time polymerase chain reaction assays to accurately determine copy number variations (CNVs) of human complement C4A, C4B, C4-long, C4-short and RCCX modules: Elucidation of C4 CNVs in 50 consanguineous subjects with defined HLA." Journal of Immunology. Vol. 179, (January 2007.): 3012-3025.

Wu H., S.A. Boackle, P. Hanvivadhanaku, D. Ulgiati, J.M. Grossman, Y. Lee, N. Shen, L.J. Abraham, T.R. Mercer, E. Park, L.A. Hebert, B.H. Rovin, D.J. Birmingham, D. Chang, C.J. Chen, D. McCurdy, H.M. Badsha, B.Y.H. Thong, H.H. Chng, F.C. Arnett, D.J. Wall. "Association of a common complement receptor 2 haplotype with increased risk of SLE." Proceedings of the National Academy of Science. Vol. 104, (January 2007.): 3961-3966.

Rovin, B.H. and L.A. Hebert. "Thiazide monotherapy for hypertension: Thiazide’s dark side just got darker." Kidney International. Vol. 72, (January 2007.): 1423-1426.

Rovin, B.H. and L.A. Hebert. "Thiazide monotherapy for hypertension: Thiazide’s dark side just got darker." Kidney International. Vol. 72, (January 2007.): 1423-1426.

Birmingham, D.J., B.H. Rovin, G. Shidham, H.N. Nagaraja, X. Zou, M. Bissel, and L.A. Hebert. "Spot urine protein/creatinine ratios are unreliable estimates of 24 hour proteinuria in most systemic lupus erythematosus nephritis flares." Kidney International. Vol. 72, (January 2007.): 865-870.

Byrd, J.C., T.S. Lin, J.T. Dalton, D. Wu, M.A. Phelps, B. Fisher, M. Moran, K.A. Blum, B. Rovin, M. Booker-McEldowney, S. Broering, L.J. Schaaf, A.J. Johnson, D.M. Lucas, N.A. Heerema, G. Lozanski, D.C. Young, J.R. Suerez, A.D. Colevas, M.R. Grever. "Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia." Blood. Vol. 109, (January 2007.): 399-404.

Roncone, D., A. Satoskar, T. Nadasdy, P. Monk, and B.H. Rovin. "Nephrotic range proteinuria in a patient receiving anti-vascular endothelial growth factor therapy for metastatic renal cell carcinoma." Nature Clinical Practice Nephrology. Vol. 3, (January 2007.): 287-293.

Rovin, B.H., D. Roncone, A. Mckinley, T. Nadasdy, S.M. Korbet, and M.M. Schwartz. "Identification of the apolipoprotein E Kyoto mutation in European Americans with lipoprotein glomerulopathy." New England Journal of Medicine. Vol. 357, (January 2007.): 2522-2524.

Mamtani, M., B. Rovin, R. Brey, J. Camargo, H. Kulkarni, M. Herrera, P. Correa, S. Holliday, J.-M., Anaya, S.K. Ahuja. "CCL3L1 gene-containing segmental duplication and polymorphisms in CCR5 affect risk of systemic lupus erythematosus." Annals of Rhuematic Diseases. Vol. in press, (January 2007.): -.

Zhang, X., M. Jin, H. Wu, N. Harris, K. T. Nadasdy, G. Nadasdy, Green-Church, H. Nagaraja, D.J. Birmingham, C.Y. Yu, L.A. Hebert, and B.H. Rovin. "Biomarker discovery for lupus nephritis through longitudinal urine proteomics.." Kidney International. no. 74. (January 2008.): 799-907.

Petri M, Kasitanon N, Singh S, Link K, Magder L, Bae SC, Hanly JG, Nived O, Sturfelt G, van Vollenhoven R, Wallace DJ, Alarcón GS, Adu D, Avila-Casado C, Bernatsky SR, Bruce IN, Clarke AE, Contreras G, Fine DM, Gladman DD, Gordon C, Kalunian KC, Madaio MP, Rovin BH, Sanchez-Guerrero J, Steinsson K, Aranow C, Balow JE, Buyon JP, Ginzler EM, Khamashta MA, Urowitz MB, Dooley MA, Merrill JT, Ramsey-Goldman R, Font J, Tumlin J, Stoll T, Zoma A. "Systemic Lupus International Collborating Clinics. Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response." Arthritis Rheum.. no. 58. (January 2008.): 1789-1795.

Petri M, Kasitanon N, Lee SS, Link K, Magder L, Bae SC, Hanly JG, Isenberg DA, Nived O, Sturfelt G, van Vollenhoven R, Wallace DJ, Alarcón GS, Adu D, Avila-Casado C, Bernatsky SR, Bruce IN, Clarke AE, Contreras G, Fine DM, Gladman DD, Gordon C, Kalunian KC, Madaio MP, Rovin BH, Sanchez-Guerrero J, Steinsson K, Aranow C, Balow JE, Buyon JP, Ginzler EM, Khamashta MA, Urowitz MB, Dooley MA, Merrill JT, Ramsey-Goldman R, Font J, Tumlin J, Stoll T, Zoma A. "Systemic Lupus International Collaborating Clinics.ystemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index." Arthritis Rheum. no. 58. (January 2008.): 1784-1788.

Hu, R.-Q., H. Mehter, T. Nadasdy, A. Satoskar, D.N. Spetie, B.H. Rovin, and L.A. Hebert. "Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review." Rheum. Int.. no. 28. (January 2008.): 1151-1164.

Birmingham, D.J., B.H. Rovin, G. Shidham, M. Bissell, H.N. Nagaraja, and L.A. Hebert. "Relationship between albuminuria and total proteinuria in SLE nephritis: Diagnostic and therapeutic implications.." Clin. J. Am. Soc. Nephrol. Vol. 3, (January 2008.): 1028-1033.

Rovin, B.H. and L.A. Hebert. "Thiazide monotherapy for hypertension: Thiazide’s dark side just got darker." Kidney International. Vol. 74, (January 2008.): 825-.

Rovin, B.H.. "The chemokine network in systemic lupus erythematosus nephritis." Frontiers in Bioscience. Vol. 13, (January 2008.): 904-922.

Collins, M., S.D. Navaneethan, M. Chung, J. Sloland, B. Goldman, G. Appel, and B.H. Rovin. "Rituximab treatment of fibrillary glomerulonephritis." American Journal of Kidney Diseases. (January 2008.): -.

Wu, H., D.J. Birmingham, B. Rovin, K.V. Hackshaw, N. Hadded, D. Haden, C.Y. Yu, and L.A. Hebert. "D-dimer level and the risk for thrombosis in systemic lupus erythematosus.." Clin. J. Am. Soc. Nephrol. no. 3. (January 2008.): 1638-1636.

Budu-Grajdeanu, P., R. Schugart, A. Friedman, C. Valentine, A. Agarwal, B.H. Rovin. "A mathematical model of venous neointimal hyperplasia formation." Theor. Biol. Med. Modelling. Vol. 2, no. 5. (January 2008.): -.

Siedner, M., A. Gelber, B.H. Rovin, A. M. McKinley, L. Christopher-Stine, B. Astor, M. Petri, and D. Fine. "Diagnostic accuracy study of urine dipstick in relation to 24 hour measurement as a screening tool for proteinuria in lupus nephritis." J. Rheum. Vol. 35, (January 2008.): 84-90.

Nori, U.S., A.K. Agarwal, and B.H. Rovin. "Comment on Teriparatide or alendronate in glucocorticoids-induced osteoporosis." New Eng. J. Med. Vol. 358, (January 2008.): 1302-1303.

Mamtani, M., B. Rovin, R. Brey, J. Camargo, H. Kulkarni, M. Herrera, P. Correa, S. Holliday, J.-M., Anaya, S.K. Ahuja. "CCL3L1 gene-containing segmental duplication and polymorphisms in CCR5 affect risk of systemic lupus erythematosus." Annals of the Rheumatic Diseases. Vol. 67, (January 2008.): 1076-1083.

Hebert LA, Birmingham DJ, Shidham G, Rovin B, Nagaraja HN, Yu CY. "Random spot urine protein/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patients." Nephron Clin Pract. Vol. 113, no. 3. (January 2009.): c177-182.

Fine DM, Ziegenbein M, Petri M, Han E, McKinley AM, Chellini J, Nagaraja HN, Carson KA, Rovin BH. "A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis." Kidney Int. Vol. 76, no. 12. (January 2009.): 1284-1288.

Zhang X, Rovin BH. "Biomarkers for lupus nephritis: The Quest Continues." Clinical J Am Soc Nephrol. Vol. 4, no. 11. (July 2009.): 1858-1865.

Rovin BH, Mckinley AM, Birmingham DJ. "Can we personalize treatment for kidney diseases." Clin J Am Soc Nephrol. Vol. 4, no. 10. (January 2009.): 1670-1676.

Yazdany, J., P. Panopalis, J.Z. Gillis, G. Schmajuk, C. MacLean, D. Wofsy, E. Yelin, E. Chakravarty, M. Dall’Era, J. Davis, J.C. Davis, R. Dixit, R. Furie, J. Grossman, K. Kalunian, L. Miller, R. Ramsey-Goldman, B. Rovin, K. Saag, N. Schwartz, J. Sanchez-Guerrero, D. Wallace, M.M. Ward. "A quality indicator set for systemic lupus erythematosus.." Arth. Rheum.. no. 61. (January 2009.): 370-377.

Schwartz N, Rubinstein T, Burkly LC, Collins CE, Blanco I, Su L, Hojaili B, Mackay M, Aranow C, Stohl W, Rovin BH, Michaelson JS, Putterman C. "Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study." Arthritis Res Ther. Vol. 11, no. 5. (January 2009.): R143-.

Merchant ML, Perkins BA, Boratyn GM, Ficociello LH, Wilkey DW, Barati MT, Bertram CC, Page GP, Rovin BH, Warram JH, Krolewski AS, Klein JB. "Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria." J Am Soc Nephrol. Vol. 20, no. 9. (January 2009.): 2065-2074.

McKinley AM, Park E, Spetie D, Hackshaw KV, Hebert L, Nagaraja S, Rovin BH. "Oral cyclophosphamide for lupus glomerulonephritis: an underused therapeutic option." Clinical J Am Soc Nephrol. Vol. 4, no. 11. (January 2009.): 1754-1760.

Hebert, L.A. and B.H. Rovin. "Uric acid and cardiovascular risk." New Eng. J. Med. Vol. 360, (January 2009.): 540-.

Rovin, B.H. "Glomerular disease: Lupus nephritis treatment: are we beyond cyclophosphamide?." Nat Rev Nephrol. Vol. 5, no. 9. (January 2009.): 492-494.

Appel, G.B., G. Contreras, M.A. Dooley, E.M. Ginzler, D. Isenberg, D. Jayne, L.S. Li, E. Mysler, J. Sanchez-Guerrero, N. Solomons, D. Wofsy, Aspreva Lupus Management Study Group (B.H. Rovin). "Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis." J. Am. Soc. Nephrol. no. 20. (January 2009.): 1103-1112.

Song, H., J. Chan, and B.H. Rovin. "Induction of chemokine expression by adiponectin in vitro is isoform dependent." Transl. Res. no. 154. (January 2009.): 18-26.

Birmingham DJ, Irshaid F, Nagaraja HN, Zou X, Tsao BP, Wu H, Yu Y, Hebert LA, Rovin BH. "The complex nature of serum C3 and C4 as biomarkers of lupus renal flare." Lupus. (January 2010.): -.

Blum W, Phelps MA, Klisovic RB, Rozewski DM, Ni W, Albanese KA, Rovin B, Kefauver, C, Devine SM, Lucas DM, Johnson A, Schaaf LJ, Byrd JC, Marcucci G, Grever MR. "Phase 1 clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias." Haematologica. Vol. 95, (January 2010.): 1098-1105.

Hebert LA, Rovin BH. "Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis." Ann Intern Med. Vol. 152, no. 1. (January 2010.): 64-Author review 65.

Budu-Grajdeanu P, Schugart RC, Friedman A, Birmingham DJ, Rovin BH. "Mathematical framework for human SLE nephritis: Disease dynamics and urine biomarkers." Biol Med Model. Vol. 14, no. 7. (January 2010.): -.

Viswanathan S, Rovin BH, Shidham GB, Raman SV, Weinberg M, Patricia A, George JN, Wu HM, Cataland SR. "Long-term, sub-clinical cardiac and renal complications in patients with multiple relapses of thrombotic thrombocytopenic purpura." Br J Haematol. Vol. 149, (January 2010.): 623-625.

Ginzler EM, Wofsy D, Isenberg D, Gordon C, Lisk L, Dooley MA: ALMS Group. "Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial." Arthritis Rheum. Vol. 62, no. 1. (January 2010.): 211-221.

Brodsky SV, Collins M, Park E, Rovin BH, Satoskar AA, Nadasdy G, Wu H, Bhatt U, Nadasdy T, Hebert LA. "Warfarin Therapy That Results in an International Normalization Ratio above the Therapeutic Range Is Associated with Accelerated Progression of Chronic Kidney Disease." Nephron Clin Pract. Vol. 115, no. 2. (January 2010.): c142-146.

Bomback AS, Song H, D’Agati VD, Cohen SD, Neal A, Appel GB, Rovin BH. "A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy." Nephrol. Dial. Transplant. (January 2010.): -.

 

Reference Works

January 1981 Rovin BH, Molnar J."Role of Plasma Fibronectin in Phagocytosis in Natural Membranous Materials" . : 3309
January 1981 Molnar J, Froehlich J, Rovin BH."Interaction of Plasma Fibronectin with Actin, Intracelular Mammalian Membranous Structures, and Bacteria" . : 849
January 1989 Schreiner G, Rovin BH, Lefkowith J."Essential Fatty Acid Deficiency Inhibits Monocyte Migration in Glomeulonephritis" . : 362
January 1989 Schreiner G, Rovin BH, Lefkowith J."Essential Fatty Acid Deficiency and Monocyte Infiltration in Glomerulonephritis" . : A446
January 1989 Rovin BH, Lefkowith JB, Schreiner G."Macrophagge Chemotaxis in the Essential Fatty Acid Deficient Rat" . : 361
January 1989 Rovin BH, Lefkowith J, Schreiner G."Glomerular Production of a Chemoattractant for White Blood Cells" . : 361
January 1989 Rovin BH, Harris KPG, Morrison A, Klahr S, Schreiner G."The Production of a Novel and Specific Macrophage Chemoattractant in Response to Ureteral Obstruction" . : A613
January 1990 Rovin BH, Wurst E, Kohan DE."Oxygen Free Radical Production by Tubular Epithelial Cells" . : 429
January 1990 Rovin BH, Lefkowith JB, Schreiner GF."Production of a Lipid Chemoattractant by Glomeruli in Experimental Glomerulonephritis" . : A463
January 1990 Rovin BH, Lefkowith JB, Lange L, Schreiner GF."Glomerular Production of a Lipid Monocyte Chemotactic Factor" . : 536
January 1990 Lefkowith JB, Rovin BH, Schreiner GF."Identification of a Chemoattractant Elaborated by Glomeruli in Experimental Glomerulonephritis" . : A891
January 1991 Tan LC, Rovin BH."Production of a Monocyte Chemotactic Factor by Cytokine-conditioned Cultured Human Mesangial Cells" . : 565
January 1991 Rovin BH, Tan LC."Low Density Lipoprotein Stimulates Production of Fibronectin by Human Mesangial Cells in Culture" . : 581
January 1992 Turman MA, Koch JL, Rovin BH, Cosio FG."Expression of Heat Shock Proteins (HSP) in Human Mesangial Cells (MC)" . : 620
January 1992 Tan L, Rovin BH."Protein Kinase C and cAMP Modulate Monocyte Chemoattractant Protein-1 Expression in Cultured Human Mesangial Cells" . : 617
January 1992 Cosio FG, Birmingham DJ, Rovin BH."Complement Activation Up-regulates Decay Accelerating Factor mRNA Through Multiple Pathways" . : 580
January 1992 Rovin BH, Cosio F, Tan L."Induction of Monocyte Chemoattractant Protein-1 in Human Mesangial Ccells by in situ Immune Complex Formation" . : 612
January 1993 Rumancik M, Rovin BH."Glomerular Expression of Monocyte Chemoattractant Protein-1 in Experimental and Human Glomerulonephritis" . : 630
January 1993 Rovin BH, Tan L."Intracellular Regulation of IL-1 Induced Monocyte Chemoattractant Protein-1 in Human Mesangial Cells" . : 498
January 1993 Nahman NS, Rovin BH, Leonhart K."Protein Kinases Modulate Fibronectin Production by Human Mesangial Cells" . : 660
January 1993 Cosio FG, Rovin BH."Complement Induction of Decay Accelerating Factor on Human Mesangial Cells: Signal Transduction Pathways" . : 598
January 1994 Rovin BH, Tan L, Dickerson J."A Regulatory Role for Protein Tyrosine Kinases in IL-1 Mediated Monocyte Chemoattractant Protein-1 Expression by Cultured Human Mesangial Cells" . : 766
January 1994 Rovin BH, Dickerson J, Hebert C, Tan L."NF-6B is Necessary but not Sufficient for IL-1 Induced Monocyte Chemoattractant-1 (MCP-1) Expression by Human Mesangial Cells" . : 766
January 1994 Nahman NS, Deucher M, Epstein D, Turman M, Rovin BH, Kronenberger J, Stauch D, Mathews A, Tan L."Fibronectin Expression in Human Mesangial Cells is Induced by Combined Oxygen-Glucose Deprivation and Regresses with Refeeding" . : 904
January 1995 Rovin BH, Dickerson J, Tan L."Intracellular Glutathione Regulates NF-6B Activation and Monocyte Chemoattractant Protein-1 Expression by Human Mesangial Cells" . : 851
January 1996 Rovin BH, Tan LC, Wewers MD, Marsh CB."Leukocyte Fc Receptor (FcyR) Cross-linking Induces MCP-1: A Model for Immune-Complex-Mediated Monocyte Recruitment" . : 1718
January 1996 Rovin, B.H., W.A. Wilmer, L.C. Tan, J.A. Dickerson, and S.S. Oei."IL-1 Activates Mitogen-Activated Protein Kinase (MAPK) and Stress-Activated Protein Kinase (SAPK) in Human Mesangial Cells (HMC) Through an Oxidation-Dependent Pathway" . : 1684
January 1997 Rovin, B.H., W.A. Wilmer, M. Danne, and J.A. Dickerson."p38 Mitogen-Activated Protein Kinase is Necessary for IL-1-Induced MCP-1 Expression by Human Mesangial Cells" . : 445
January 1997 Rovin, B.H., M. Danne, M.D. Wewers, and C. Marsh."Lymphocyte Fc Receptor Cross-Linking Mediates Human Renal Cell MCP-1 Production Through an IL-1-Dependent Pathway" . : 484
January 1997 Rovin, B.H., and M. Danne."Nitric Oxide Does not Mediate or Modulate IL-1-Induced MCP-1 Expression by Human Mesangial Cells" . : 444
January 1997 Wilmer WA, Dickerson JA, Rovin BH."Jun-NH2-Terminal Kinase Activation by Protein Phosphatase Inhibition in Human Mesangial Cells" . : 449
January 1997 Rovin BH, Allred LK."Expression of Duffy Antigen/Receptor for Chemokines (DARC) During Human Renal Disease" . : 483
January 1998 Rovin BH, Lu L, Saxena DD."Expression of the IL-8 Receptor CXCR1 by Human Renal Parenchymal Cells and the Human Kidney" . : 468
January 1998 Rovin BH, Lu L, Phan LT."Genetic Variation in the MCP-1 Gene Regulatory Region: Association with Lupus Nephritis" . : 467
January 1999 Rovin BH, Lu L, Saxena R."A Novel Polymorphism in the MCP-1 Gene 5'-regulatory Region Influences MCP-1 Expression" . : 536
January 2000 Wilmer WA, Rovin BH, Dixon CL, Lu L."Peroxisome Proliferator-activated Receptors (PPARs) Induce the Extracellular-regulated Kinases (ERKs) in Human Mesangial Cells (HMC)" . : 436A
January 2000 Rovin BH, Lu L, Wang Y."Regulation of Mesangial Cell Chemokine Expression Through Endogenous Anti-inflammatory Mechanisms" . : 498A
January 2000 Rovin BH, Lu L."Role of Chemokine Polymorphisms in Determining the Severity of Renal Inflammation in SLE" . : 96A
January 2000 Bhatt UY, Plott DT, Fu J, Rovin BH, Nahman NS."Bone Marrow Engraftment and Acute Renal Failure" . : 126A
January 2000 37. Panzer, U., A. Schneider, U. Wenzel, P. Barth, J. Becker, G. Zahner, U. Helmchen, B. Rovin, F.P. Schena, D. Cusi, G.D’Amico, F. Berthoux, R.A.K. Stahl."The chemokine receptor CCR-532 mutation is associated with better renal function in patients with IgA nephropathy" . : 94A
January 2001 Rovin, B.H., W.A. Wilmer, L. Lu, C. Dixon, A.I. Doseff, and T. Hilbelink."The cyclopentenone prostaglandin 15-deoxy-12,14-PGJ2 regulates human mesangial cell proliferation and survival" . : 620A
January 2001 Wilmer, W.A., C. L. Dixon, L. Lu, and B.H. Rovin."J-series prostaglandins and ciglitazone inhibit TGF-1 expression by human mesangial cells" . : 720A
January 2002 Rovin, B.H., L. Lu, C. L. Dixon, W.A. Wilmer, and J.B. Klein."Mesangial expression of heat shock protein 70 in response to treatment with 15-deoxy-12,14-prostaglandin J2 is a defense mechanism against cell death" . : 293A
January 2002 Rovin BH, Lu L, Zhang X."A Novel Interleukins-8 Polymorphism is Associated with Severe SLE Nephritis" . : 514A
January 2002 Yang Y, Chung EK, Tsao BP, Zhou B, Higgins G, Rennebohm RM, Birmingham DJ, Rovin BH, Hebert LA, Yu CY."A Quantitative Genetic Trait for Human Lupus: Low and High Gene Dosages of Complement C4 in SLE Patients" . : 12A
January 2003 Rovin, B.H., X. Zhang, W.A. Wilmer, L. Lu, C. Dixon, H. Song, and X. Chen."Pathways of stress protein activation in 15-deoxy-12,14-prostaglandin J2" . : 84A
January 2003 Thongboonkerd V, Barati M, McLeish KR, Rovin BH, Pierce WM, Epstein PN, Klein JB."Altered Elastase Inhibitor and Elastin Expression in Type 2 Diabetic Kidneys Defined by Proteomic Analysis" . : 600A
January 2003 Chung EK, Rovin BH, Lu L, Yang Y, Yu CY."Differential Expression of Complement Components C4A and C4B in Human Kidney Cells" . : 634A
January 2004 Rovin BH, Zhang X, Chen HZ, Chen XL, Song H."A Novel Regulator of Chemokine Expression: Linking Oxidative Stress to Inflammation" . : 474A
January 2004 Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN."Urine Chemokines as Biomarkers of Human SLE Activity" . : 54A
January 2005 Rovin BH, Song H, Hebert LA, Nadasdy T, Nadasdy G, Birmingham DJ, Yu CY, Nagaraja HN."Expression of Adiponectin in Human Lupus Nephritis" . : 7A
January 2005 Rovin BH, Campbell S, Kollaros M, Burkly L, Michaelson J, Putterman C."Urinary Tweak in Systemic Lupus Erythematosus: A Novel Biomarker for Lupus Nephritis?" . : S198
January 2005 Hebert LA, Rovin BH, Nagaraja HN, Birmingham DJ, Spetie L."Association of SLE Flare with Increased Self-perceived Stress Variability" . : 528A
January 2006 Nadasdy, T., G. Nadasdy, G. Agarwal, A. Satoskar, M. Mauer, A. Agarwal, D. Spetie, B.H. Rovin, and L.A. Hebert."Idiopathic thick glomerular basement membrane nephropathy: A newly recognized cause of glomerular hematuria" . : 258A
January 2006 Khanna, B., C. Valentine, H.N. Nagaraja, B.H. Rovin, and L.A. Hebert."Fenofibrate-induced increase in serum creatinine in chronic kidney disease does not appear to be the result of nephrotoxicity or increased creatinine production" . : 384A
January 2006 Birmingham, D.J., H.N. Nagaraja, B.H. Rovin, L. Spetie, Y. Zhao, X. Li, K.V. Hackshaw, C.Y. Yu, W.B. Malarkey, and L.A. Hebert."Fluctuation in self-perceived stress increases risk of flare in SLE nephritis patients carrying the 5-HT1A-1019 Allele" . : 731A
January 2006 Yang, Y., L.A. Hebert, E.K. Chung, H.N. Nagaraja, Y.L. Wu, B. Zhou, M. Hebert, K. Hackshaw, D.J. Birmingham, B.H. Rovin, and C.Y. Yu."Caucasian patients with systemic lupus erythematosus nephritis have low C4A gene copy numbers and low plasma C4 protein levels" . : 801A
January 2006 Yang, Y., E.K. Chung, Y.L. Wu, H.N. Nagaraja, B. Zhou, M. Hebert, K. Jones, B.P. Tsao, D.J. Birmingham, B.H. Rovin, L.A. Hebert, and C.Y. Yu."Complement C4 gene copy number variation in human autoimmune disease systemic lupus erythematosus" . : 265A
January 2006 Schwartz N, Su L, Burkly LC, gao HX, Aranow C, Mackay M, Michaelson JS, Rovin BH, Putterman C."Urinary TWEAK is a Novel Biomarker for Lupus Nephritis" . : S456
January 2006 Rovin BH, Nadasdy G, Nuovo G, Song H, Nadasdy T."Expression of Adiponectin and its Receptors in the Kidney During SLE Nephritis" .
January 2006 Roncone D, SOng H, Cooke G, Rovin BH."Identification of the Apolipoprotein E Kyoto Mutation in a Caucasian American with Lipoprotein Glomerulopathy" .
January 2006 Appel GB, Looney RJ, Eisenberg RA, Rovin BH, Ginzler EM, Adler SG, Brunetta P, Garg JP."Protocol for the Lupus Nephritis Assessment with Rituximab (LUNAR) Study" .
January 2007 Plott, D.T., D.J. Birmingham, B.H. Rovin, L.A. Hebert, and U.Y. Bhatt."Association of air quality index and renal flares of systemic lupus erythematosus" . : 823A
January 2007 Hebert, L.A., B.H. Rovin, G. Shidham, D.J. Birmingham, H.N. Nagaraja."To reliably estimate 24-hour proteinuria to diagnose SLE GN flare, the protein/creatinine ratio of an intended 24-hour urine collection that is 50% or more complete is better than a spot urine protein/creatinine ratio" . : 556A
January 2007 Hebert, L.A., B.H. Rovin, G. Shidham, D.J. Birmingham, and H.N. Nagaraja."Relationship between albuminuria and total proteinuria in SLE GN: Diagnostic and therapeutic implications" . : 566A
January 2007 Chellini, J., C. Valentine, B.H. Rovin, and L.A. Hebert."In chronic kidney disease patients fenofibrate-induced increases in serum creatinine are reversible despite years of fenofibrate therapy" . : 553A
January 2007 Zhang, X., M. Jin, H. Wu, N. Harris, H. Nagaraja, D. Birmingham, C.Y. Yu, and B.H. Rovin."Biomarker discovery for lupus nephritis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry" . : 789A
January 2007 Yu, C.Y., Y. Yan, Y.L. Wu, N. Esack, A. Aziz, L.S. Hiremath, K.V. Hackshaw, D.J. Birmingham, B.H. Rovin, H.N. Nagaraja, and L.A. Hebert."Relevant genetic and clinical predictors of complement C4 protein levels and SLE disease flares" . : 780A
January 2007 Rovin, B.H., H. Wu, D.J. Birmingham, N. Haddad, L.A. Hebert."Relationship between the level of high sensitivity D-dimer and the risk of clotting in SLE" . : 630A
January 2007 Rovin, B.H., D.J. Birmingham, H. Nagaraja, C.Y. Yu, and L.A. Hebert."Evaluation of the performance of traditional biomarkers for the diagnosis or prediction of renal flare in patients with lupus nephritis" . : 779A
January 2007 Bhatt, U.Y., D.J. Birmingham, B.H. Rovin, and L.A. Hebert."Seasonal variation in renal and non-renal systemic lupus erythematosus flares" . : 825A

Presentations

"Visiting Professor." . (January 1993)

"Visiting Professor." . (January 1994)

"Activation of Nuclear Factor-6B Correlates with IL-1-induced Monocyte Chemoattractant Protein-1 Expression by Human Mesangial Cells." Presented at Fourth International Chemokine Symposium, . (January 1995)

"Visiting Professor." . (January 1995)

"Visiting Professor." . (January 1996)

"Visiting Professor." . (January 1999)

"Visiting Professor." . (January 1999)

"Visiting Professor." . (January 1999)

"Visiting Professor." . (January 2001)

"Visiting Professor." . (January 2002)

"Visiting Professor/Consultant." . (January 2003)

"Visiting Professor." . (January 2003)

"Urinary Chemokines as Biomarkers of SLE Activity." Presented at 7th International Congress on SLE and Related Conditions, . (January 2004)

"Visiting Professor." . (January 2005)

"Visiting Professor." . (January 2005)

"Visiting Professor." . (January 2006)

"Second Annual Susac’s Syndrome Seminar." . (January 2006)

"Visiting Professor." . (January 2007)

"Visiting Professor." . (January 2007)

"Faculty Member for Seminar in Advanced Rheumatology." . (January 2007)

"Visiting Professor." . (January 2008)

"Visiting Professor." . (January 2008)

"Second International Lupus Flare Conference." . (January 2008)

"Quality Indicators for Lupus Workshop." San Francisco. (January 2008)

"Biannual SLE Research Conference." . (January 2008)

"Mayo Clinic International Seminar in Nephrology." . (January 2009)

"Grand Rounds Speaker." . (January 2009)

"Basic Scientists and Clinicians-Get Connected." Presented at Research Education Program, . (January 2009)

"Visiting Professor." . (January 2009)

"Visiting Professor." . (January 2009)

"Visiting Professor." . (January 2009)

"Visiting Professor." . (January 2010)

"Visiting Professor." . (January 2010)

"First Imperial College and Transplant Institute Lupus Meeting." . (January 2010)

 

Professional Activities

1995 - present Medical Research Council.
1995 - present National Research Council.
1995 - present Canadian Research Council.
1995 - present Veterans Administration Merit Review Board.
1995 - present National Kidney Foundation Fellowship Review Committee.
2002 - present SCORs in SLE. NIAMS Study Section.
2004 - present Pathobiology of Kidney Disease. NIDDK Study Section.
2005 - present Clinical Studies of Kidney Diseases. NIDDK Study Section.
2005 - present Program Projects in SLE. NIAID Study Section.
2007 - present George O’brien Kidney Center Awards. NIDDK Study Section.
2007 - present Pathobiology of Kidney Disease. NIDDK Study Section.
2008 - present George O’brien Kidney Center Awards. NIDDK Study Section.
2008 - present Biannual SLE Research Conference. University of California, San Francisco.
2008 - present Second International Lupus Flare Conference. Washington, DC.
2008 - present Quality Indicators of Lupus Workshop. San Francisco, CA.
2009 - present Challenge Grant Content Review. NIDDK Study Section.
2009 - present American Society of Nephrology Grant Review Committee.
2010 - present Osperey Pharmaceuticals.
2010 - present Questcor Pharmaceuticals.
2010 - present Genetech.
2010 - present Teijan Pharmaceuticals.
2010 - present Centocor Research and Development.
2010 - present Novo Nordisk.
2010 - present Veterans Administration Merit Review Board.
 

Technical Reports

Arthritis & Rheumatism. Vol. 54 pg 421-432, Columbus, OH: (January 2006).

Rovin, B.H., D.J. Birmingham, H.N. Nagaraja, C.Y. Yu, and L.A. Hebert. Biomarker discovery in human SLE nephritis. 65: 187-193 ed. no. NYU Hosp. Joint Dis. NYC: (January 2007).

Rovin, B.H., D.J. Birmingham, H.N. Nagaraja, C.Y. Yu, and L.A. Hebert. Biomarker discovery in human SLE nephritis. NYC: (January 2007).